Clinical Trial Detail

NCT ID NCT02675946
Title Study of CGX1321 in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Curegenix Inc.
Indications

pancreatic adenocarcinoma

Advanced Solid Tumor

colorectal adenocarcinoma

hepatocellular carcinoma

bile duct carcinoma

gastric adenocarcinoma

esophageal carcinoma

Therapies

CGX1321

Age Groups: adult senior

No variant requirements are available.